Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date NantHealth: Payer Readiness for Autoimmune Biosimilars Dr. Tiffany Avery, CMO, NantHealth; Dr. Neha Bhanusali, Board certified in Rheumatology and Internal Medicine NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the introduction of biosim... March 29, 2023 5:00pm A Hybrid Approach to Continuous Biomanufacturing of Biosimilars Andrew Falconbridge at Alvotech and Melisa Caprio at Repligen There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end op... 2 months ago | 84 mins Raw Material Lot Variability Challenges During Manufacturing of Biosimilars mab Sekhar Reddy, DSP Lead for Biosimilars at Biocon MSAT Downstream processing of Biosimilar Monoclonal Antibody utilises variety of raw materials that a critical for achieving the desired product quality. I... 4 years ago | 34 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 62 mins Biosimilar Naming: How Could the Suffix Impact the U.S. Health System? Eric Henry, PharmD, Clinical Content Specialist with Clinical Effectiveness at Wolters Kluwer, Heath Join Eric Henry, Clinical Content Specialist focused on the domestic drug file with Clinical Effectiveness at Wolters Kluwer, Heath, in a 45-minute li... 4 years ago | 45 mins Implementing CMC Strategies for scale-up operations in biologics manufacturing Dr Anita Krishnan, Lupinand -Dr. Annu Uppal, Global Demo Lead and Advanced Workflow Specialist at SCIEX Biotechnological products are so complex, that manufacturing biologics which are both cost-effective and with best product quality, is a technical cha... 4 years ago | 73 mins Extractables and Leachables Testing Using a Quality Risk Management Approach Dhaval Tapiawala, Principal Scientist at Pfizer and Dr. Dennis Jenke, Principal Consultant for Nelson Labs Presented by Dhaval Tapiawala, Principal Scientist at Pfizer • Understanding extractables and leachables for better adoption of single use systems • ... 3 years ago | 108 mins Is India Anywhere Closer to Implementing Continuous Bioprocessing Narasimha Rao Nedunuri, CEO of CLONZ Biotech, and José Castillo, PhD, CTo and co-founder of Univercells Continuous processing has been widely employed in many biological manufacturing processes. In recent years it gained the momentum in the field of Bios... 5 years ago | 66 mins Platform tech development for biosimilar upscaling Dr Hung Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech Discover strategies to move candidate molecules through development Building consistent, straightforward processes with low variability Exploring the ... 5 years ago | 68 mins Disruption and maturity: the future directions for biologics in healthcare Paul Tunnah (moderator), Angela McFarlane, Sarah Rickwood, Margaret Dolan and Timothy C. de Gavre A digital debate analysing the future for biologics in the UK and the factor affecting market access in this territory. Our expert panel will cover a ... 6 years ago | 65 mins
